Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Xiaole Shirley Liu
Dana Farber Cancer Inst, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
GV20 Oncotherapy
Other : chairman of the fiduciary board of directors
Please see attachment.
Regulators of Cancer Immunotherapy Response
PROJECT NARRATIVE Cancer immunotherapies have emerged over the last decade as highly promising approaches for cancer treatment, although only subsets of patients respond to immunotherapies. We propose to integrate computational modeling with functional genomics techniques to refine the immunotherapy response biomarkers, identify novel regulators of immunotherapy response, and elucidate their underlying mechanisms, with the potential to improve immunotherapy response.
Filed on June 26, 2019.
Tell us what you know about Xiaole Shirley Liu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Xiaole Shirley Liu filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $10,000 - $19,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $10,000 - $19,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $10,000 - $19,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $10,000 - $19,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $0 - $4,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $0 - $4,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | $0 - $4,999 |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | Value cannot be readily determined |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | Value cannot be readily determined |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | Value cannot be readily determined |
| Xiaole Shirley Liu | Dana Farber Cancer Inst | Conflict of Interest | GV20 Oncotherapy | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.